The differential diagnosis of Parkinson's disease

European Journal of Neurology

Volumn 9, Issue SUPPL. 3, 2002, Pages 23-30

  Poewe, Werner ^a   Wenning, G ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

CBD; Differential diagnosis; DLB; MSA; Parkinsonism; PD; PSP

Indexed keywords

ALZHEIMER DISEASE; APRAXIA; AUTONOMIC DYSFUNCTION; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; DEMENTIA; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; EARLY DIAGNOSIS; HUMAN; IDIOPATHIC DISEASE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SHY DRAGER SYNDROME;

EID: 0036460702     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.9.s3.3.x     Document Type: Review

References (46)

1. Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT (2000). MRI volumetrie correlates of white matter lesions in dementia with Lewy bodies and Alzheimer's disease. Int J Geriatric Psychiatry 15:911-916.
2. Beck RO, Betts CD, Fowler CJ (1994). Genitourinary dysfunction in multiple system atrophy: Clinical features and treatment in 62 cases. J Urol 151:1336-1341.
3. Bösch SM, Wenning GK, Ransmayr G, Poewe W (2002). Dystonia in multiple system atrophy. J Neurol, Neurosurgery Psychiatry 72:300-303.
4. Bower JH, Maraganore DM, McDonnell SK, Rocca WA (1997). Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976-90. Neurology 49:1284-1288.
5. Brown RG, Marsden CD (1984). How common is dementia in Parkinson's disease? Lancet 2:1262-1265.
6. Cummings JL, Litvan I (2000). Neuropsychiatric aspects of corticobasal degeneration. In: Litvan I, Goetz CG, Lang AE, eds. Corticobasal Degeneration. Advances in Neurology, Vol. 82. Lippincott, Williams & Wilkins, Philadelphia, pp. 147-152.
7. Di Maria E, Tabaton M, Vigo T et al. (2000). Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol 47:374-377.
8. Donnemiller E, Heilmann J, Wenning GK et al. (1997). Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTcECD and 123I-β-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. European J Nuclear Med 24:320-325.
9. Forno LS (1969). Concentric hyaline intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases). Relationship to Parkinsonism. J Am Geriatric Soc 17: 557-575.
10. Gibb WR, Lees AJ (1988). The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745-752.
11. Gibb WRG, Luthert PJ, Marsden CD (1989). Corticobasal degeneration. Brain 112:1171-1192.
12. Gilman S, Low PA, Quinn N et al. (1998). Consensus statement on the diagnosis of multiple system atrophy. J Autonomic Nervous System 74:189-192.
13. Hohl U, Tiraboschi P, Hansen LA et al. (2000). Diagnostic accuracy of dementia with Lewy bodies. Arch Neural 57: 347-351.
14. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (1992b). What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study. Neurology 42:1142-1146.
15. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ (2002). The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125:861-870.
16. Hughes AJ, Daniel SE, Blankson S, Lees AJ (1993). A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 50:140-148.
17. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992a). Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol, Neurosurgery Neuropsychiatry 55:181-184.
18. Hughes AJ, Daniel SE, Lees AJ (2001). Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 57:1497-1499.
19. Kertesz A, Martinez-Lage P, Davidson W, Munoz DG (2000). The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology 55: 1368-1375.
20. Klawans HL, Palelogos N (1986). Dystonia-Parkinson syndrome: Differential effects of levodopa and dopamine agonists. Clin Neuropharmacol 9:298-302.
21. Kompoliti K, Goetz CG, Boeve BF, Maraganore DM et al. (1998). Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol 55:957-961.
22. Kosaka K (1990). Diffuse Lewy body disease in Japan. J Neurol 237:197-204.
23. Kosaka K, Yoshimura M, Ikeda K et al. (1984). Diffuse type of Lewy body disease: Progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree a new disease? Clin Neuropathol 3:185-192.
24. LeWitt PA, Burns RS, Newman RP (1986). Dystonia in untreated parkinsonism. Clin Neuropharmacol 9:293-297.
25. Litvan I (1997). Progressive supranuclear palsy and corticobasal degeneration. Bailliere's Clin Neurol 6:167-185.
26. Litvan I, Agid Y, Calne D et al. (1996a). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop. Neurology 47:1-9.
27. Litvan I, Agid Y, Goetz C et al. (1997). Accuracy of the clinical diagnosis of corticobasal degeneration: A clinicopathological study. Neurology 57:1184-1189.
28. Litvan I, Mangone CA, McKee A et al. (1996b). Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: A clinicopathological study. J Neurol, Neurosurgery Psychiatry 60:615-620.
29. Litvan I, McIntrye A, Goetz CG et al. (1998). Accuracy of the clinical diagnosis of Lewy body disease, Parkinson's disease and dementia with Lewy bodies. Arch Neurol 55:969-978.
30. Lücking CB, Durr A, Bonifati V, Vaughan J et al. (2000). Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N Engl J Med 342:1560-1567.
31. Mayeux R, Denaro J, Hemenegildo N, Marder K et al. (1992). A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol 49:492-497.
32. McKeith IG, Galasko D, Kosaka K et al. (1996). Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 47:113-124.
33. McKeith IG, Galasko D, Wilcock GK, Byrne EJ (1995). Lewy body dementia: Diagnosis and treatment. Br J Psychiatry 167:709-717.
34. McKeith IG, O'Brien J, Ballard C (1999a). Diagnosing dementia with Lewy bodies. Lancet 354:1227-1228.
35. McKeith IG, Perry EK, Perry RH for the consortium on dementia with Lewy bodies (1999b). Report of the Second Dementia with Lewy body International Workshop. Neurology 53:902-905.
36. Poewe WH, Lees AJ, Stern GM (1988). Dystonia in Parkinson's disease: Clinical and pharmacological features. Ann Neurol 23:73-78.
37. Rebeiz JJ, Kolodny EH, Richardson EP (1967). Corticodentationigral degeneration with neuronal achromasia: A progressive disorder of late adult life. Transactions Am Neurol Assoc 92:23-26.
38. Riley DE, Lang AE, Lewis A et al. (1990). Cortical-basal ganglionic degeneration. Neurology 40:1203-1212.
39. Rinne JO, Lee MS, Thompson PD, Marsden CD (1994). Corticobasal degeneration: A clinical study of 36 cases. Brain 117:1183-1196.
40. Schrag A, Ben-Shlomo Y, Brown R et al. (1998). Young-onset Parkinson's disease revisited - Clinical features, natural history, and mortality. Movement Disorders 13:885-894.
41. Schrag A, Ben-Shlomo Y, Quinn NP (1999). Prevalence of progressive supranuclear palsy and multiple system atrophy: A cross-sectional study. Lancet 354:1771-1775.
42. Watts RL, Mirra SS, Young RR (1989). Corticobasal ganglionic degeneration (CBDG) with neuronal achromasia: Clinical-pathological study of two cases. Neurology 39:140.
43. Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP (1994). Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 117:835-845.
44. Wenning GK, Ben-Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP (2000). What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol, Neurosurgery Psychiatry 68: 434-440.
45. Wenning GK, Litvan I, Jankovic J, Granata R et al. (1998). Natural history and survival of 14 patients with corticobasal degeneration confirmed at post-mortem examination. J Neurol, Neurosurgery Psychiatry 64:184-189.
46. Wenning GK, Seppi K, Poewe W et al. (2001). Differential association of orthostatic hypotension with the cerebellar versus parkinsonian presentation of multiple system atrophy. Neurology 56:A444.